These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
86 related items for PubMed ID: 7482078
21. Ductal shunting and effective systemic blood flow following single dose surfactant treatment in the premature baboon with hyaline membrane disease. Kinsella JP, Gerstmann DR, Gong AK, Taylor AF, deLemos RA. Biol Neonate; 1991; 60(5):283-91. PubMed ID: 1790252 [Abstract] [Full Text] [Related]
22. Two controlled trials of dry artificial surfactant: early effects and later outcome in babies with surfactant deficiency. Wilkinson A, Jenkins PA, Jeffrey JA. Lancet; 1985 Aug 10; 2(8450):287-91. PubMed ID: 2862464 [Abstract] [Full Text] [Related]
25. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. Long W, Corbet A, Cotton R, Courtney S, McGuiness G, Walter D, Watts J, Smyth J, Bard H, Chernick V. N Engl J Med; 1991 Dec 12; 325(24):1696-703. PubMed ID: 1944470 [Abstract] [Full Text] [Related]
30. Hyaline membrane disease treated with bovine surfactant. Smyth JA, Metcalfe IL, Duffty P, Possmayer F, Bryan MH, Enhorning G. Pediatrics; 1983 Jun 12; 71(6):913-7. PubMed ID: 6687937 [Abstract] [Full Text] [Related]
31. Randomised double-blind controlled trial of effect of morphine on catecholamine concentrations in ventilated pre-term babies. Quinn MW, Wild J, Dean HG, Hartley R, Rushforth JA, Puntis JW, Levene MI. Lancet; 1993 Aug 07; 342(8867):324-7. PubMed ID: 8101584 [Abstract] [Full Text] [Related]
32. Exogenous surfactant replacement therapy of hyaline membrane disease in premature infants. Namgung R, Lee C, Suh JS, Park KI, Han DG. Yonsei Med J; 1989 Dec 07; 30(4):355-66. PubMed ID: 2697112 [Abstract] [Full Text] [Related]
33. Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease. Phibbs RH, Ballard RA, Clements JA, Heilbron DC, Phibbs CS, Schlueter MA, Sniderman SH, Tooley WH, Wakeley A. Pediatrics; 1991 Jul 07; 88(1):1-9. PubMed ID: 2057244 [Abstract] [Full Text] [Related]
39. Treatment of hyaline membrane disease by human amniotic fluid surfactant. Jin HZ, Chen C, Jin QL, Shao XM. Chin Med J (Engl); 1989 Dec 07; 102(12):944-6. PubMed ID: 2517741 [Abstract] [Full Text] [Related]